<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Posts on Ed Palmer</title>
    <link>https://doced.github.io/posts/</link>
    <description>Recent content in Posts on Ed Palmer</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Fri, 29 Jul 2022 00:00:00 +0000</lastBuildDate><atom:link href="https://doced.github.io/posts/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Randomised Controlled Trials: Anything But Fragile</title>
      <link>https://doced.github.io/posts/randomised-controlled-trials-anything-but-fragile/</link>
      <pubDate>Fri, 29 Jul 2022 00:00:00 +0000</pubDate>
      
      <guid>https://doced.github.io/posts/randomised-controlled-trials-anything-but-fragile/</guid>
      <description>Preamble In response to the deluge of studies that reappraise previously conducted studies with the fragility index and the permeation of this method into prominant aspects of the medical community, I wrote this editorial some years ago. Sadly, I could not get the article picked up by a medical journal, and so I am posting it here. I hope this is of use.
Introduction In 2014, the fragility index was proposed to evaluate the strength of evidence provided by a randomised controlled trial (RCT) (1).</description>
    </item>
    
  </channel>
</rss>
